Tuomas Mirtti

机构：University of Helsinki, Helsinki University Hospital, Finnish Cancer Registry, Finland University, Cancer Society of Finland, Hospital District of Helsinki and Uusimaa · ORCID：0000-0003-0455-9891

发表论文 480 篇 · 总被引 5537 次 · h-index 39

代表论文

• Site-Dependent Decoupling of Drug-Biomarker Associations in Clear Cell Renal Cell Carcinoma Revealed by Functional Profiling of Patient-Derived Cell Models (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 2)
• Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma (2026 · BJUI Compass)
• Pathway-centric multi-omics and functional precision medicine reveal shared drug vulnerabilities in heterogeneous adult Wilms tumor (2026 · bioRxiv (Cold Spring Harbor Laboratory))
• IP02-28 AI-INFORMED QUANTITATIVE MITOSIS INDEX PREDICTS BCG MAINTENANCE THERAPY BENEFIT IN HIGH-RISK NON–MUSCLE-INVASIVE BLADDER CANCER (2026 · The Journal of Urology)
• PD15-11 AI-BASED ANALYSIS OF PERIVASCULAR REGIONS FROM H&E PREDICTS SURVIVAL IN MUSCLE-INVASIVE BLADDER CANCER (2026 · The Journal of Urology)
• Abstract 792: A standardized pan-cancer framework for spatial profiling of the tumor microenvironment using multiplex immunofluorescence. (2026 · Cancer Research)